Son Mikyung, CEO of Genaxis, Receives 'Top Female Accelerator Award'... "Expanding Investment Sectors"

[Asia Economy Reporter Kim Bo-kyung] Startup accelerator Genaxis announced on the 11th that its CEO Son Mi-kyung received the 'Best Female Accelerator Award' from the Korea Accelerator Association (KAA) and the Korea Women Venture Association.

Genaxis, registered as an accelerator with the Ministry of SMEs and Startups in 2019, actively conducted investment and incubation projects last year, discovering and investing in early-stage startups with high growth potential.

Having built close networks with domestic and international investors, academia, and industry, Genaxis has currently completed the formation of a total of 13 individual investment associations. Including the recently formed The Nest No.1 individual investment association, it is managing investment funds totaling over 7.5 billion KRW and executed investments in 15 companies last year.

Among these, 'Wayne Hills Bryant AI' and 'Rokit Healthcare' are scheduled to be listed on the KOSDAQ market this year, raising expectations for Genaxis's rapid investment recovery.

Operating its own incubation program, Genaxis supported a total of five companies last year through the incubation and investment attraction program under the Korea Health Industry Development Institute's investment attraction support project. Through the 'Korea University Laboratory Startup Investment Attraction Support Program,' it conducted incubation programs for six early-stage companies.

Not only did Genaxis successfully attract investments from domestic venture capital (VC), but it also secured residency and joint clinical trials at Harvard Spalding Hospital Open Innovation Center, established a joint venture with Russia's SberHealthcare, and achieved VC fundraising in Singapore amounting to 100 million USD.

Genaxis plans to make aggressive seed investments at 2.5 times last year's level this year. It also intends to actively invest in Series A and B stage companies to further expand its investment portfolio.

Son Mi-kyung, CEO of Genaxis, stated, "Until now, Genaxis has focused investments in the pharmaceutical bio and digital healthcare sectors, but this year we plan to expand into future industries such as artificial intelligence, food tech, environment and energy, and robotics. We will continue to secure investment resources through active fund formation and grow as a competitive accelerator by being selected as a TIPS operator."

This content was produced with the assistance of AI translation services.